Adhesion
0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PharmasyntezSeroguard
PharmasyntezSeroguard
Baxter InternationalCoseal
Baxter InternationalADEPT
Clinical Trials (4)
Total enrollment: 517 patients across 4 trials
Efficacy and Dose Ranging Study of Seroguard
Start: May 2017Est. completion: Jan 2018114 patients
Phase 2Completed
Safety and Tolerability of Seroguard Use
Start: May 2015Est. completion: Oct 201550 patients
Phase 1Completed
PMCF Study for COSEAL® in Gynecologic Surgery
Start: Jun 2024Est. completion: May 2025200 patients
N/ACompleted
PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery
Start: Jun 2023Est. completion: May 2024153 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.